Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions

Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM m...

Full description

Bibliographic Details
Main Authors: Yancheng Lai, Xiaole Lu, Yankai Liao, Pei Ouyang, Hai Wang, Xian Zhang, Guanglong Huang, Songtao Qi, Yaomin Li
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-03-01
Series:Genes and Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352304223003252
_version_ 1797731023006466048
author Yancheng Lai
Xiaole Lu
Yankai Liao
Pei Ouyang
Hai Wang
Xian Zhang
Guanglong Huang
Songtao Qi
Yaomin Li
author_facet Yancheng Lai
Xiaole Lu
Yankai Liao
Pei Ouyang
Hai Wang
Xian Zhang
Guanglong Huang
Songtao Qi
Yaomin Li
author_sort Yancheng Lai
collection DOAJ
description Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM malignant progression and recurrence, which might be a breakthrough to understand GBM heterogeneity and overcome treatment resistance. PMT is a complicated process influenced by crosstalk between GBM and tumor microenvironment, depending on intricate ligand-receptor interactions. In this review, we summarize the autocrine and paracrine pathways in the GBM microenvironment and related ligand-receptor interactions inducing PMT. We also discuss the current therapies targeting the PMT-related autocrine and paracrine pathways. Together, this review offers a comprehensive understanding of the failure of GBM-targeted therapy and ideas for future tendencies of GBM treatment.
first_indexed 2024-03-12T11:52:57Z
format Article
id doaj.art-6c4a8cd8dd684b6c96fc58b3b5060b77
institution Directory Open Access Journal
issn 2352-3042
language English
last_indexed 2024-03-12T11:52:57Z
publishDate 2024-03-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Genes and Diseases
spelling doaj.art-6c4a8cd8dd684b6c96fc58b3b5060b772023-08-31T05:03:11ZengKeAi Communications Co., Ltd.Genes and Diseases2352-30422024-03-01112874889Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactionsYancheng Lai0Xiaole Lu1Yankai Liao2Pei Ouyang3Hai Wang4Xian Zhang5Guanglong Huang6Songtao Qi7Yaomin Li8Department of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Corresponding authors. Guangzhou Dadao Bei Street 1838#, Guangzhou, Guangdong 510515, China. Fax: +86 20 61641806.Department of Neurosurgery, Institute of Brain Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Laboratory for Precision Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China; Corresponding authors. Guangzhou Dadao Bei Street 1838#, Guangzhou, Guangdong 510515, China. Fax: +86 20 61641806.Glioblastoma (GBM) is the most common intrinsic and aggressive primary brain tumor in adults, with a median survival of approximately 15 months. GBM heterogeneity is considered responsible for the treatment resistance and unfavorable prognosis. Proneural-mesenchymal transition (PMT) represents GBM malignant progression and recurrence, which might be a breakthrough to understand GBM heterogeneity and overcome treatment resistance. PMT is a complicated process influenced by crosstalk between GBM and tumor microenvironment, depending on intricate ligand-receptor interactions. In this review, we summarize the autocrine and paracrine pathways in the GBM microenvironment and related ligand-receptor interactions inducing PMT. We also discuss the current therapies targeting the PMT-related autocrine and paracrine pathways. Together, this review offers a comprehensive understanding of the failure of GBM-targeted therapy and ideas for future tendencies of GBM treatment.http://www.sciencedirect.com/science/article/pii/S2352304223003252AutocrineGlioblastomaLigand-receptor interactionMicroenvironmentParacrineProneural-mesenchymal transition
spellingShingle Yancheng Lai
Xiaole Lu
Yankai Liao
Pei Ouyang
Hai Wang
Xian Zhang
Guanglong Huang
Songtao Qi
Yaomin Li
Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
Genes and Diseases
Autocrine
Glioblastoma
Ligand-receptor interaction
Microenvironment
Paracrine
Proneural-mesenchymal transition
title Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
title_full Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
title_fullStr Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
title_full_unstemmed Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
title_short Crosstalk between glioblastoma and tumor microenvironment drives proneural–mesenchymal transition through ligand-receptor interactions
title_sort crosstalk between glioblastoma and tumor microenvironment drives proneural mesenchymal transition through ligand receptor interactions
topic Autocrine
Glioblastoma
Ligand-receptor interaction
Microenvironment
Paracrine
Proneural-mesenchymal transition
url http://www.sciencedirect.com/science/article/pii/S2352304223003252
work_keys_str_mv AT yanchenglai crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT xiaolelu crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT yankailiao crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT peiouyang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT haiwang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT xianzhang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT guanglonghuang crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT songtaoqi crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions
AT yaominli crosstalkbetweenglioblastomaandtumormicroenvironmentdrivesproneuralmesenchymaltransitionthroughligandreceptorinteractions